Iron chelators as anti-infectives; malaria as a paradigm

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 3-4, 1999, Pages 289-298

  Cabantchik, Z Ioav ^a   Moody Haupt, Susan ^a   Gordeuk, Victor R ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chelator; Chemotherapy; Erythrocyte; Hemoglobin; Iron; Malaria

Indexed keywords

ANTIINFECTIVE AGENT; DEFEROXAMINE; HEMOGLOBIN; HYDRAZONE DERIVATIVE; IRON; IRON CHELATING AGENT; PYRIDONE DERIVATIVE; SIDEROPHORE;

ANTIBACTERIAL ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE; HUMAN; MACROPHAGE; MALARIA; MALARIA CONTROL; PARASITE DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033485356     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00153-4     Document Type: Article

References (25)

1. Aria A.E., Corredor A. Low response of Colombian strain of Plasmodium vivax to classical antimalarial therapy. Trop. Med. Parasitol. 40:1989;21-23.
2. Bruce-Chwatt, L.J. (1988) History of malaria from prehistory to eradication. In: Malaria, Principles of Malarialogy (Wernsdorfer, W.H. and McGregor, I.A., Eds.), pp. 1-60. Churchill-Livingstone, New York.
3. Bullen, J.J. and Griffiths, E. (1987) Iron and Infection: Molecular, Physiological and Clinical Aspects, pp. 1-27. Wiley.
4. Cabantchik Z.I. Iron chelators as antimalarials. The biochemical basis of cytotoxicity. Parasitol. Today. 11:1995;74-78.
5. Francis S.E., Sullivan D.J. Jr., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:1997;97-123.
6. Ginsburg H., Famin O., Zhang J., Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol. 56:1998;1305-1313.
7. Golenser J., Domb A., Teomim B., Tsafack A., Nissim O., Ponka P., Eling W., Cabantchik Z.I. The treatment of animal models of malaria with iron chelators using a novel polymeric device for slow drug release. J. Pharmacol. Exp. Ther. 281:1997;1127-1135.
8. Gordeuk V.R., Thuma P.E., Brittenham G.M., McLaren C., Parry D., Backenstose A., Biemba G., Msiska R., Holmes L., McKinley E., Vargas L., Gilkeson R., Poltera A.A. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327:1992;1473.
9. Harrison, G. (1978) Mosquitoes, Malaria and Man: a History of the Hostilities Since 1880. E.P. Dutton, New York.
10. Hider, R.C. (1994) In: The Develoment of Iron Chelators for Clinical Use (Bergeron, R.J. and Brittenham, G.M., Eds.), pp. 353-394. CRC Press.
11. Kumaratilake L.M., Ferrante A., Kumaratilake J.S., Allison A.C. Extraction of intraerythrocytic malarial parasites by phagocytic cells. Parasitol. Today. 10:1994;193-196.
12. Lytton, S.J., Mester, B., Libman, J., Shanzer, A. and Cabantchik, Z.I. (1994) Progress in Iron Research (Hershko et al., Eds.), pp. 385-397. Plenum Press, NY.
13. Mabeza G., Loyevsky M., Gordeuk V.R., Weiss G. Iron chelation for malaria: a review. Pharmacol. Ther. 81:1998;53-75.
14. Meshnick S.R., Taylor T.E., Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:1996;301-315.
15. Murray M.J., Murray A.B., Murray M.B., Murray C.J. The adverse effect of iron repletion on the course of certain infections. Br. Med. J. 2:1978;1113-1115.
16. Patayorro M.E., Amador R., Clavijo P., et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 3432:1988;158-161.
17. Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol. Today. 3:1987;241-246.
18. Rosenthal P.J. Proteases of malaria parasites: new targets for chemotherapy. Emerg. Infect. Dis. 4:1998;49-57.
19. Rouault T.A., Klausner R.D. Regulation of iron metabolism in eukaryotes. Curr. Top. Cell. Reg. 35:1997;1-19.
20. Schnitzer B., Sodeman T., Mead M.L. Pitting function of the spleen in malaria: ultrastructural observations. Science. 177:1972;175-177.
21. Tanner M., Teuscher T., Alonso P.L. The first malaria vaccine. Parasitol. Today. 11:1995;10-13.
22. Tsafack, A., Golenser, J. and Cabantchik, Z.I. (1996) Antimalarial action of iron chelators. In: Molecular Biology of Hematopoiesis (Abraham, N.G., Asano, S., Brittinger, G. and Shadduck, R., Eds.), pp. 671-676. Plenum Press, NY.
23. Tsai, Y.L. and Krogstad, D.J. (1988) The resurgence of malaria. In: Emerging Infections 2 (Scheld, W.M., Craig, W.A. and Hughes, J.M., Eds.), pp. 195-212. Am. Soc. Microb., Washington, DC.
24. Weinberg G.A. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob. Agents Chemother. 38:1994;997-1003.
25. WHO (1995) 12th Programme report of the UNDP/World Bank/WHO special TDR. Bull. WHO 12, pp. 64-76.